Ethical Considerations in Pay-for-Performance Programs for Diabetes
Author(s)
Vutova Y1, Dacheva A2, Slavchev G3, Djambazov S4
1HTA Ltd., Sofia, 22, Bulgaria, 2Medtronic International Trading Sàrl, Sofia, 23, Bulgaria, 3Medtronic International Trading Sàrl, Sofia, 22, Bulgaria, 4Medical University Pleven, Pleven, Bulgaria
Presentation Documents
OBJECTIVES: This abstract aims to explore the ethical considerations surrounding pay-for-performance (P4P) programs for diabetes care.
METHODS: Ethical considerations related to P4P programs for diabetes care are analyzed based on a literature review and critical evaluation of existing research and ethical frameworks. Key ethical principles, including fairness, equity, autonomy, beneficence, and nonmaleficence, are considered in the context of P4P implementation.
RESULTS: Ethical concerns in P4P programs for diabetes care arise due to potential unintended consequences and ethical tensions. These include the risk of cherry-picking patients, potential neglect of complex cases, and the impact on health disparities. P4P programs may inadvertently incentivize providers to prioritize achieving performance metrics over holistic patient care, potentially compromising patient-centeredness and the provider-patient relationship.
CONCLUSIONS: Ethical considerations play a crucial role in the design and implementation of P4P programs for diabetes care. To ensure ethical practice, it is essential to consider the potential unintended consequences and ethical tensions associated with financial incentives. Policymakers and healthcare professionals must carefully balance the goals of quality improvement and patient outcomes with the ethical principles of fairness, equity, and patient-centered care. Transparent communication, stakeholder involvement, and ongoing evaluation are crucial to address ethical concerns and mitigate potential unintended consequences. A thoughtful and inclusive approach that values patient autonomy, considers the needs of diverse patient populations, and promotes equitable care delivery is necessary to achieve the desired outcomes while upholding ethical standards.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 11, S2 (December 2023)
Code
HPR134
Topic
Health Policy & Regulatory, Real World Data & Information Systems
Topic Subcategory
Data Protection, Integrity, & Quality Assurance, Pricing Policy & Schemes, Public Spending & National Health Expenditures, Risk-sharing Approaches
Disease
Diabetes/Endocrine/Metabolic Disorders (including obesity)